The Chief Financial Officer of BioScrip Inc (NASDAQ: BIOS) is Buying SharesBy Carrie Williams
Following this transaction Jeffrey Kreger’s holding in the company was increased by 79.19%. In addition to Jeffrey Kreger, 2 other BIOS executives reported Buy trades in the last month.
The company has a one year high of $3.43 and a one year low of $1.15. Currently, BioScrip Inc has an average volume of 2.02M.
Six different firms, including Barrington and Craig-Hallum, currently also have a Buy rating on the stock.
The insider sentiment on BioScrip Inc has been positive according to 25 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
BioScrip, Inc. provides home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The firm offers post-acute solutions, infusion services, and respiratory care services and home medical equipment. The company was founded in 1996 and is headquartered in Denver, CO.